GO:0051761 | sesquiterpene metabolic process | 17.89% (17/95) | 4.98 | 0.0 | 0.0 |
GO:0051762 | sesquiterpene biosynthetic process | 17.89% (17/95) | 4.98 | 0.0 | 0.0 |
GO:0003824 | catalytic activity | 76.84% (73/95) | 1.22 | 0.0 | 0.0 |
GO:0106223 | germacrene A hydroxylase activity | 12.63% (12/95) | 5.71 | 0.0 | 0.0 |
GO:0046246 | terpene biosynthetic process | 18.95% (18/95) | 4.02 | 0.0 | 0.0 |
GO:0016491 | oxidoreductase activity | 35.79% (34/95) | 2.42 | 0.0 | 0.0 |
GO:0004497 | monooxygenase activity | 22.11% (21/95) | 3.49 | 0.0 | 0.0 |
GO:0042214 | terpene metabolic process | 18.95% (18/95) | 3.9 | 0.0 | 0.0 |
GO:0018674 | (S)-limonene 3-monooxygenase activity | 10.53% (10/95) | 6.05 | 0.0 | 0.0 |
GO:0019113 | limonene monooxygenase activity | 10.53% (10/95) | 5.94 | 0.0 | 0.0 |
GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 20.0% (19/95) | 3.62 | 0.0 | 0.0 |
GO:0008610 | lipid biosynthetic process | 29.47% (28/95) | 2.66 | 0.0 | 0.0 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 23.16% (22/95) | 3.2 | 0.0 | 0.0 |
GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 14.74% (14/95) | 4.37 | 0.0 | 0.0 |
GO:0008299 | isoprenoid biosynthetic process | 22.11% (21/95) | 3.19 | 0.0 | 0.0 |
GO:0062150 | amorpha-4,11-diene 12-monooxygenase activity | 8.42% (8/95) | 6.56 | 0.0 | 0.0 |
GO:0006720 | isoprenoid metabolic process | 23.16% (22/95) | 3.02 | 0.0 | 0.0 |
GO:0120251 | hydrocarbon biosynthetic process | 18.95% (18/95) | 3.52 | 0.0 | 0.0 |
GO:0120252 | hydrocarbon metabolic process | 18.95% (18/95) | 3.43 | 0.0 | 0.0 |
GO:0044255 | cellular lipid metabolic process | 30.53% (29/95) | 2.31 | 0.0 | 0.0 |
GO:0046872 | metal ion binding | 38.95% (37/95) | 1.85 | 0.0 | 0.0 |
GO:0043169 | cation binding | 38.95% (37/95) | 1.82 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 46.32% (44/95) | 1.56 | 0.0 | 0.0 |
GO:0102934 | costunolide synthase activity | 8.42% (8/95) | 5.64 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 44.21% (42/95) | 1.57 | 0.0 | 0.0 |
GO:0043167 | ion binding | 48.42% (46/95) | 1.42 | 0.0 | 0.0 |
GO:0034003 | vetispiradiene synthase activity | 5.26% (5/95) | 7.68 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 42.11% (40/95) | 1.59 | 0.0 | 0.0 |
GO:0006629 | lipid metabolic process | 30.53% (29/95) | 2.02 | 0.0 | 0.0 |
GO:0005506 | iron ion binding | 13.68% (13/95) | 3.62 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 72.63% (69/95) | 0.87 | 0.0 | 0.0 |
GO:0102698 | 5-epi-aristolochene synthase activity | 5.26% (5/95) | 7.31 | 0.0 | 0.0 |
GO:0009987 | cellular process | 83.16% (79/95) | 0.67 | 0.0 | 0.0 |
GO:0020037 | heme binding | 12.63% (12/95) | 3.6 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 65.26% (62/95) | 0.95 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 68.42% (65/95) | 0.89 | 0.0 | 0.0 |
GO:0046906 | tetrapyrrole binding | 12.63% (12/95) | 3.34 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 87.37% (83/95) | 0.54 | 0.0 | 0.0 |
GO:0016835 | carbon-oxygen lyase activity | 10.53% (10/95) | 3.67 | 0.0 | 0.0 |
GO:0102170 | 5-epi-aristolochene-1,3-dihydroxylase activity | 5.26% (5/95) | 6.2 | 0.0 | 0.0 |
GO:0009699 | phenylpropanoid biosynthetic process | 15.79% (15/95) | 2.7 | 0.0 | 0.0 |
GO:0009698 | phenylpropanoid metabolic process | 16.84% (16/95) | 2.57 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 87.37% (83/95) | 0.52 | 0.0 | 1e-06 |
GO:0019748 | secondary metabolic process | 21.05% (20/95) | 2.11 | 0.0 | 1e-06 |
GO:0046686 | response to cadmium ion | 14.74% (14/95) | 2.67 | 0.0 | 2e-06 |
GO:0003674 | molecular_function | 85.26% (81/95) | 0.51 | 0.0 | 2e-06 |
GO:0045338 | farnesyl diphosphate metabolic process | 6.32% (6/95) | 4.83 | 0.0 | 3e-06 |
GO:0045339 | farnesyl diphosphate catabolic process | 5.26% (5/95) | 5.48 | 0.0 | 4e-06 |
GO:0046914 | transition metal ion binding | 17.89% (17/95) | 2.18 | 0.0 | 6e-06 |
GO:0044550 | secondary metabolite biosynthetic process | 16.84% (16/95) | 2.21 | 0.0 | 1.1e-05 |
GO:0008150 | biological_process | 85.26% (81/95) | 0.47 | 0.0 | 1.2e-05 |
GO:0016106 | sesquiterpenoid biosynthetic process | 5.26% (5/95) | 5.05 | 0.0 | 1.5e-05 |
GO:1901362 | organic cyclic compound biosynthetic process | 23.16% (22/95) | 1.71 | 1e-06 | 2.1e-05 |
GO:0031224 | intrinsic component of membrane | 26.32% (25/95) | 1.52 | 1e-06 | 3.2e-05 |
GO:0032787 | monocarboxylic acid metabolic process | 16.84% (16/95) | 2.09 | 1e-06 | 3.3e-05 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 9.47% (9/95) | 3.11 | 1e-06 | 3.5e-05 |
GO:0102518 | (11Z)-eicosenoate 14-hydroxylase activity | 3.16% (3/95) | 7.1 | 1e-06 | 3.5e-05 |
GO:0016829 | lyase activity | 12.63% (12/95) | 2.53 | 1e-06 | 3.5e-05 |
GO:0044238 | primary metabolic process | 55.79% (53/95) | 0.81 | 1e-06 | 3.7e-05 |
GO:0044283 | small molecule biosynthetic process | 16.84% (16/95) | 2.04 | 2e-06 | 4.5e-05 |
GO:0019637 | organophosphate metabolic process | 14.74% (14/95) | 2.21 | 2e-06 | 5.4e-05 |
GO:0044242 | cellular lipid catabolic process | 8.42% (8/95) | 3.28 | 2e-06 | 5.4e-05 |
GO:0016115 | terpenoid catabolic process | 6.32% (6/95) | 4.04 | 2e-06 | 5.5e-05 |
GO:0010038 | response to metal ion | 16.84% (16/95) | 2.0 | 2e-06 | 5.7e-05 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 9.47% (9/95) | 3.0 | 2e-06 | 5.7e-05 |
GO:0045485 | omega-6 fatty acid desaturase activity | 3.16% (3/95) | 6.81 | 2e-06 | 5.8e-05 |
GO:0050183 | phosphatidylcholine 12-monooxygenase activity | 3.16% (3/95) | 6.81 | 2e-06 | 5.8e-05 |
GO:0102985 | delta12-fatty-acid desaturase activity | 3.16% (3/95) | 6.81 | 2e-06 | 5.8e-05 |
GO:0102987 | palmitoleic acid delta 12 desaturase activity | 3.16% (3/95) | 6.81 | 2e-06 | 5.8e-05 |
GO:0010334 | sesquiterpene synthase activity | 5.26% (5/95) | 4.56 | 2e-06 | 6.1e-05 |
GO:0008300 | isoprenoid catabolic process | 6.32% (6/95) | 3.97 | 3e-06 | 6.4e-05 |
GO:0006096 | glycolytic process | 5.26% (5/95) | 4.48 | 3e-06 | 7.7e-05 |
GO:0006757 | ATP generation from ADP | 5.26% (5/95) | 4.48 | 3e-06 | 7.7e-05 |
GO:0046031 | ADP metabolic process | 5.26% (5/95) | 4.44 | 4e-06 | 8.8e-05 |
GO:1901360 | organic cyclic compound metabolic process | 35.79% (34/95) | 1.12 | 4e-06 | 0.0001 |
GO:0009395 | phospholipid catabolic process | 5.26% (5/95) | 4.39 | 4e-06 | 0.0001 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 5.26% (5/95) | 4.36 | 5e-06 | 0.000108 |
GO:0016021 | integral component of membrane | 23.16% (22/95) | 1.53 | 5e-06 | 0.000109 |
GO:0009135 | purine nucleoside diphosphate metabolic process | 5.26% (5/95) | 4.35 | 5e-06 | 0.000111 |
GO:0036109 | alpha-linolenic acid metabolic process | 3.16% (3/95) | 6.46 | 5e-06 | 0.000111 |
GO:0005886 | plasma membrane | 31.58% (30/95) | 1.21 | 6e-06 | 0.000123 |
GO:0102895 | colneleate synthase activity | 2.11% (2/95) | 8.68 | 6e-06 | 0.000124 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 5.26% (5/95) | 4.31 | 6e-06 | 0.000125 |
GO:0006714 | sesquiterpenoid metabolic process | 5.26% (5/95) | 4.27 | 7e-06 | 0.000138 |
GO:0006165 | nucleoside diphosphate phosphorylation | 5.26% (5/95) | 4.27 | 7e-06 | 0.000138 |
GO:0000287 | magnesium ion binding | 8.42% (8/95) | 2.99 | 8e-06 | 0.00016 |
GO:0019752 | carboxylic acid metabolic process | 18.95% (18/95) | 1.71 | 8e-06 | 0.000161 |
GO:0046939 | nucleotide phosphorylation | 5.26% (5/95) | 4.2 | 8e-06 | 0.000167 |
GO:0019438 | aromatic compound biosynthetic process | 18.95% (18/95) | 1.7 | 9e-06 | 0.000173 |
GO:0006091 | generation of precursor metabolites and energy | 9.47% (9/95) | 2.73 | 9e-06 | 0.000179 |
GO:0009132 | nucleoside diphosphate metabolic process | 5.26% (5/95) | 4.03 | 1.5e-05 | 0.000286 |
GO:0016114 | terpenoid biosynthetic process | 9.47% (9/95) | 2.64 | 1.5e-05 | 0.000287 |
GO:0010333 | terpene synthase activity | 5.26% (5/95) | 4.01 | 1.6e-05 | 0.000302 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 4.21% (4/95) | 4.73 | 1.6e-05 | 0.000304 |
GO:0009820 | alkaloid metabolic process | 9.47% (9/95) | 2.63 | 1.6e-05 | 0.000304 |
GO:0016042 | lipid catabolic process | 8.42% (8/95) | 2.78 | 2.3e-05 | 0.000428 |
GO:0016838 | carbon-oxygen lyase activity, acting on phosphates | 5.26% (5/95) | 3.89 | 2.4e-05 | 0.000431 |
GO:0006721 | terpenoid metabolic process | 10.53% (10/95) | 2.37 | 2.5e-05 | 0.000443 |
GO:0006090 | pyruvate metabolic process | 5.26% (5/95) | 3.8 | 3.2e-05 | 0.00057 |
GO:0044281 | small molecule metabolic process | 24.21% (23/95) | 1.31 | 3.5e-05 | 0.000608 |
GO:0016836 | hydro-lyase activity | 5.26% (5/95) | 3.74 | 3.9e-05 | 0.000676 |
GO:0016102 | diterpenoid biosynthetic process | 6.32% (6/95) | 3.26 | 4.1e-05 | 0.000701 |
GO:0047834 | D-threo-aldose 1-dehydrogenase activity | 3.16% (3/95) | 5.41 | 4.9e-05 | 0.00083 |
GO:0001676 | long-chain fatty acid metabolic process | 4.21% (4/95) | 4.33 | 5e-05 | 0.000831 |
GO:0072330 | monocarboxylic acid biosynthetic process | 9.47% (9/95) | 2.42 | 4.9e-05 | 0.000834 |
GO:0009117 | nucleotide metabolic process | 9.47% (9/95) | 2.42 | 5e-05 | 0.000836 |
GO:0016053 | organic acid biosynthetic process | 12.63% (12/95) | 1.98 | 5.1e-05 | 0.000848 |
GO:0046034 | ATP metabolic process | 5.26% (5/95) | 3.65 | 5.2e-05 | 0.000852 |
GO:0016020 | membrane | 47.37% (45/95) | 0.75 | 5.5e-05 | 0.000892 |
GO:0006753 | nucleoside phosphate metabolic process | 9.47% (9/95) | 2.39 | 5.7e-05 | 0.000919 |
GO:0043436 | oxoacid metabolic process | 18.95% (18/95) | 1.48 | 6.4e-05 | 0.001017 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 5.26% (5/95) | 3.56 | 7.1e-05 | 0.001118 |
GO:0009150 | purine ribonucleotide metabolic process | 7.37% (7/95) | 2.77 | 7.8e-05 | 0.001221 |
GO:0005783 | endoplasmic reticulum | 14.74% (14/95) | 1.72 | 8.1e-05 | 0.001246 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 5.26% (5/95) | 3.49 | 8.8e-05 | 0.001321 |
GO:0102614 | germacrene A acid 8beta-hydroxylase activity | 2.11% (2/95) | 7.1 | 8.7e-05 | 0.001323 |
GO:0050236 | pyridoxine:NADP 4-dehydrogenase activity | 2.11% (2/95) | 7.1 | 8.7e-05 | 0.001323 |
GO:1901141 | regulation of lignin biosynthetic process | 5.26% (5/95) | 3.47 | 9.5e-05 | 0.001414 |
GO:0046394 | carboxylic acid biosynthetic process | 11.58% (11/95) | 2.0 | 9.7e-05 | 0.001438 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 5.26% (5/95) | 3.45 | 0.0001 | 0.001462 |
GO:0006163 | purine nucleotide metabolic process | 7.37% (7/95) | 2.71 | 0.000103 | 0.001499 |
GO:0006725 | cellular aromatic compound metabolic process | 30.53% (29/95) | 1.02 | 0.000105 | 0.001519 |
GO:0033559 | unsaturated fatty acid metabolic process | 4.21% (4/95) | 4.04 | 0.000107 | 0.001538 |
GO:0009056 | catabolic process | 21.05% (20/95) | 1.31 | 0.000124 | 0.001766 |
GO:0009259 | ribonucleotide metabolic process | 7.37% (7/95) | 2.66 | 0.000128 | 0.001809 |
GO:0006082 | organic acid metabolic process | 18.95% (18/95) | 1.4 | 0.000131 | 0.001825 |
GO:0005985 | sucrose metabolic process | 4.21% (4/95) | 3.96 | 0.000135 | 0.001866 |
GO:0035835 | indole alkaloid biosynthetic process | 4.21% (4/95) | 3.93 | 0.000145 | 0.00199 |
GO:0019693 | ribose phosphate metabolic process | 7.37% (7/95) | 2.62 | 0.000149 | 0.002029 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 9.47% (9/95) | 2.19 | 0.000165 | 0.002234 |
GO:0006644 | phospholipid metabolic process | 7.37% (7/95) | 2.57 | 0.000187 | 0.002498 |
GO:0009141 | nucleoside triphosphate metabolic process | 5.26% (5/95) | 3.26 | 0.000186 | 0.002506 |
GO:0043403 | skeletal muscle tissue regeneration | 2.11% (2/95) | 6.51 | 0.000208 | 0.002582 |
GO:0050184 | phosphatidylcholine desaturase activity | 2.11% (2/95) | 6.51 | 0.000208 | 0.002582 |
GO:0102855 | 1-18:1-2-18:2-phosphatidylcholine desaturase activity | 2.11% (2/95) | 6.51 | 0.000208 | 0.002582 |
GO:0102857 | 1-18:1-2-18:3-phosphatidylcholinedesaturase activity | 2.11% (2/95) | 6.51 | 0.000208 | 0.002582 |
GO:0102860 | 1-18:1-2-18:2-phosphatidylcholine synthase activity | 2.11% (2/95) | 6.51 | 0.000208 | 0.002582 |
GO:0102861 | 1-18:2-2-18:1-phosphatidylcholine desaturase activity (SN2-18:2 forming) | 2.11% (2/95) | 6.51 | 0.000208 | 0.002582 |
GO:0102871 | 1-16:0-2-18:1-phosphatidylcholine desaturase activity | 2.11% (2/95) | 6.51 | 0.000208 | 0.002582 |
GO:0009821 | alkaloid biosynthetic process | 6.32% (6/95) | 2.85 | 0.000197 | 0.002611 |
GO:0016101 | diterpenoid metabolic process | 6.32% (6/95) | 2.84 | 0.0002 | 0.002633 |
GO:1901575 | organic substance catabolic process | 18.95% (18/95) | 1.35 | 0.000203 | 0.002645 |
GO:0005488 | binding | 68.42% (65/95) | 0.45 | 0.000219 | 0.002699 |
GO:0062197 | cellular response to chemical stress | 7.37% (7/95) | 2.52 | 0.000228 | 0.00279 |
GO:0072341 | modified amino acid binding | 4.21% (4/95) | 3.75 | 0.000231 | 0.002806 |
GO:0080142 | regulation of salicylic acid biosynthetic process | 3.16% (3/95) | 4.63 | 0.000251 | 0.003028 |
GO:0005829 | cytosol | 28.42% (27/95) | 1.0 | 0.000255 | 0.003062 |
GO:0010035 | response to inorganic substance | 22.11% (21/95) | 1.17 | 0.000307 | 0.003652 |
GO:1901000 | regulation of response to salt stress | 6.32% (6/95) | 2.72 | 0.000318 | 0.003705 |
GO:0042551 | neuron maturation | 2.11% (2/95) | 6.23 | 0.000317 | 0.003723 |
GO:1902458 | positive regulation of stomatal opening | 3.16% (3/95) | 4.51 | 0.000315 | 0.003729 |
GO:0035834 | indole alkaloid metabolic process | 5.26% (5/95) | 3.08 | 0.000334 | 0.003868 |
GO:0051287 | NAD binding | 4.21% (4/95) | 3.59 | 0.000359 | 0.004136 |
GO:0072521 | purine-containing compound metabolic process | 7.37% (7/95) | 2.4 | 0.000382 | 0.004376 |
GO:0006749 | glutathione metabolic process | 4.21% (4/95) | 3.56 | 0.00039 | 0.004431 |
GO:0030957 | Tat protein binding | 3.16% (3/95) | 4.34 | 0.000452 | 0.005104 |
GO:0080141 | regulation of jasmonic acid biosynthetic process | 3.16% (3/95) | 4.32 | 0.000474 | 0.00532 |
GO:0080140 | regulation of jasmonic acid metabolic process | 3.16% (3/95) | 4.29 | 0.000497 | 0.005541 |
GO:0071229 | cellular response to acid chemical | 5.26% (5/95) | 2.94 | 0.00052 | 0.005765 |
GO:0005984 | disaccharide metabolic process | 4.21% (4/95) | 3.43 | 0.000545 | 0.006 |
GO:0046434 | organophosphate catabolic process | 5.26% (5/95) | 2.91 | 0.000556 | 0.006049 |
GO:0009734 | auxin-activated signaling pathway | 6.32% (6/95) | 2.57 | 0.000556 | 0.006082 |
GO:0033591 | response to L-ascorbic acid | 2.11% (2/95) | 5.78 | 0.000601 | 0.006499 |
GO:0004033 | aldo-keto reductase (NADP) activity | 3.16% (3/95) | 4.16 | 0.000649 | 0.006969 |
GO:0010055 | atrichoblast differentiation | 2.11% (2/95) | 5.68 | 0.000686 | 0.007326 |
GO:0016769 | transferase activity, transferring nitrogenous groups | 3.16% (3/95) | 4.04 | 0.000827 | 0.008728 |
GO:0016125 | sterol metabolic process | 4.21% (4/95) | 3.27 | 0.000826 | 0.008766 |
GO:0047484 | regulation of response to osmotic stress | 6.32% (6/95) | 2.44 | 0.000874 | 0.009166 |
GO:1903426 | regulation of reactive oxygen species biosynthetic process | 3.16% (3/95) | 3.98 | 0.000927 | 0.009666 |
GO:0010337 | regulation of salicylic acid metabolic process | 3.16% (3/95) | 3.95 | 0.000998 | 0.010281 |
GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 3.16% (3/95) | 3.95 | 0.000998 | 0.010281 |
GO:0086019 | cell-cell signaling involved in cardiac conduction | 2.11% (2/95) | 5.36 | 0.001079 | 0.010993 |
GO:0086070 | SA node cell to atrial cardiac muscle cell communication | 2.11% (2/95) | 5.36 | 0.001079 | 0.010993 |
GO:0043295 | glutathione binding | 3.16% (3/95) | 3.88 | 0.001149 | 0.011569 |
GO:1900750 | oligopeptide binding | 3.16% (3/95) | 3.88 | 0.001149 | 0.011569 |
GO:0005740 | mitochondrial envelope | 2.11% (2/95) | 5.29 | 0.001191 | 0.011856 |
GO:0006006 | glucose metabolic process | 3.16% (3/95) | 3.86 | 0.001189 | 0.011904 |
GO:0043231 | intracellular membrane-bounded organelle | 50.53% (48/95) | 0.53 | 0.001251 | 0.012381 |
GO:2000762 | regulation of phenylpropanoid metabolic process | 5.26% (5/95) | 2.65 | 0.001262 | 0.012422 |
GO:0007507 | heart development | 3.16% (3/95) | 3.83 | 0.001272 | 0.012447 |
GO:0042246 | tissue regeneration | 2.11% (2/95) | 5.23 | 0.001308 | 0.012734 |
GO:0033273 | response to vitamin | 3.16% (3/95) | 3.79 | 0.001358 | 0.013 |
GO:0009407 | toxin catabolic process | 3.16% (3/95) | 3.79 | 0.001358 | 0.013 |
GO:0005798 | Golgi-associated vesicle | 3.16% (3/95) | 3.79 | 0.001358 | 0.013 |
GO:0006817 | phosphate ion transport | 3.16% (3/95) | 3.76 | 0.001447 | 0.013783 |
GO:0016052 | carbohydrate catabolic process | 6.32% (6/95) | 2.28 | 0.001533 | 0.014525 |
GO:0042383 | sarcolemma | 2.11% (2/95) | 5.1 | 0.001558 | 0.014601 |
GO:0010053 | root epidermal cell differentiation | 4.21% (4/95) | 3.02 | 0.001555 | 0.014651 |
GO:0005975 | carbohydrate metabolic process | 11.58% (11/95) | 1.51 | 0.001622 | 0.015123 |
GO:0043227 | membrane-bounded organelle | 50.53% (48/95) | 0.52 | 0.001633 | 0.015143 |
GO:1904368 | regulation of sclerenchyma cell differentiation | 2.11% (2/95) | 5.04 | 0.001691 | 0.015516 |
GO:1904369 | positive regulation of sclerenchyma cell differentiation | 2.11% (2/95) | 5.04 | 0.001691 | 0.015516 |
GO:1900367 | positive regulation of defense response to insect | 3.16% (3/95) | 3.6 | 0.002006 | 0.018317 |
GO:0009311 | oligosaccharide metabolic process | 4.21% (4/95) | 2.91 | 0.002049 | 0.018614 |
GO:1900376 | regulation of secondary metabolite biosynthetic process | 5.26% (5/95) | 2.48 | 0.002087 | 0.018854 |
GO:0044248 | cellular catabolic process | 15.79% (15/95) | 1.19 | 0.002127 | 0.019117 |
GO:0008202 | steroid metabolic process | 5.26% (5/95) | 2.47 | 0.002187 | 0.019557 |
GO:0042631 | cellular response to water deprivation | 4.21% (4/95) | 2.88 | 0.002224 | 0.019791 |
GO:0006740 | NADPH regeneration | 2.11% (2/95) | 4.83 | 0.002274 | 0.020132 |
GO:0006575 | cellular modified amino acid metabolic process | 4.21% (4/95) | 2.86 | 0.002297 | 0.020233 |
GO:0044304 | main axon | 2.11% (2/95) | 4.78 | 0.002432 | 0.020505 |
GO:0007584 | response to nutrient | 4.21% (4/95) | 2.84 | 0.002447 | 0.020528 |
GO:0033853 | aspartate-prephenate aminotransferase activity | 1.05% (1/95) | 8.68 | 0.00243 | 0.020588 |
GO:0033854 | glutamate-prephenate aminotransferase activity | 1.05% (1/95) | 8.68 | 0.00243 | 0.020588 |
GO:0035605 | peptidyl-cysteine S-nitrosylase activity | 1.05% (1/95) | 8.68 | 0.00243 | 0.020588 |
GO:0035606 | peptidyl-cysteine S-trans-nitrosylation | 1.05% (1/95) | 8.68 | 0.00243 | 0.020588 |
GO:0051873 | killing by host of symbiont cells | 1.05% (1/95) | 8.68 | 0.00243 | 0.020588 |
GO:0010898 | positive regulation of triglyceride catabolic process | 1.05% (1/95) | 8.68 | 0.00243 | 0.020588 |
GO:0004364 | glutathione transferase activity | 3.16% (3/95) | 3.51 | 0.002361 | 0.020592 |
GO:0006796 | phosphate-containing compound metabolic process | 17.89% (17/95) | 1.09 | 0.002358 | 0.020671 |
GO:0032868 | response to insulin | 3.16% (3/95) | 3.49 | 0.002487 | 0.020767 |
GO:1901564 | organonitrogen compound metabolic process | 34.74% (33/95) | 0.67 | 0.002541 | 0.021119 |
GO:0071462 | cellular response to water stimulus | 4.21% (4/95) | 2.82 | 0.002563 | 0.021206 |
GO:0007267 | cell-cell signaling | 3.16% (3/95) | 3.45 | 0.002684 | 0.022098 |
GO:0006793 | phosphorus metabolic process | 17.89% (17/95) | 1.06 | 0.00282 | 0.02311 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 2.11% (2/95) | 4.64 | 0.002938 | 0.023858 |
GO:0010765 | positive regulation of sodium ion transport | 2.11% (2/95) | 4.64 | 0.002938 | 0.023858 |
GO:0006103 | 2-oxoglutarate metabolic process | 2.11% (2/95) | 4.6 | 0.003117 | 0.024964 |
GO:0019685 | photosynthesis, dark reaction | 2.11% (2/95) | 4.6 | 0.003117 | 0.024964 |
GO:0086065 | cell communication involved in cardiac conduction | 2.11% (2/95) | 4.6 | 0.003117 | 0.024964 |
GO:0030176 | integral component of endoplasmic reticulum membrane | 3.16% (3/95) | 3.35 | 0.003255 | 0.025953 |
GO:0018675 | (S)-limonene 6-monooxygenase activity | 2.11% (2/95) | 4.56 | 0.003301 | 0.026197 |
GO:0006631 | fatty acid metabolic process | 7.37% (7/95) | 1.85 | 0.003394 | 0.026814 |
GO:0006952 | defense response | 24.21% (23/95) | 0.84 | 0.003423 | 0.026925 |
GO:1990170 | stress response to cadmium ion | 2.11% (2/95) | 4.51 | 0.003489 | 0.027085 |
GO:0005315 | inorganic phosphate transmembrane transporter activity | 2.11% (2/95) | 4.51 | 0.003489 | 0.027085 |
GO:0006928 | obsolete movement of cell or subcellular component | 2.11% (2/95) | 4.51 | 0.003489 | 0.027085 |
GO:0009755 | hormone-mediated signaling pathway | 11.58% (11/95) | 1.35 | 0.003844 | 0.029706 |
GO:0031227 | intrinsic component of endoplasmic reticulum membrane | 3.16% (3/95) | 3.26 | 0.003896 | 0.029976 |
GO:0007165 | signal transduction | 20.0% (19/95) | 0.94 | 0.003969 | 0.030404 |
GO:0071470 | cellular response to osmotic stress | 4.21% (4/95) | 2.63 | 0.004057 | 0.030947 |
GO:0050896 | response to stimulus | 52.63% (50/95) | 0.44 | 0.004082 | 0.031005 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 3.16% (3/95) | 3.21 | 0.004243 | 0.031949 |
GO:0009938 | negative regulation of gibberellic acid mediated signaling pathway | 3.16% (3/95) | 3.21 | 0.004243 | 0.031949 |
GO:0030324 | lung development | 2.11% (2/95) | 4.36 | 0.004293 | 0.032052 |
GO:0030017 | sarcomere | 2.11% (2/95) | 4.36 | 0.004293 | 0.032052 |
GO:0004450 | isocitrate dehydrogenase (NADP+) activity | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0060696 | regulation of phospholipid catabolic process | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:1903976 | negative regulation of glial cell migration | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:1904464 | regulation of matrix metallopeptidase secretion | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:1904465 | negative regulation of matrix metallopeptidase secretion | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0008863 | formate dehydrogenase (NAD+) activity | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0009326 | formate dehydrogenase complex | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0015945 | methanol metabolic process | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0015946 | methanol oxidation | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0030416 | methylamine metabolic process | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0042183 | formate catabolic process | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0018119 | peptidyl-cysteine S-nitrosylation | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0007215 | glutamate receptor signaling pathway | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0007216 | G protein-coupled glutamate receptor signaling pathway | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0032591 | dendritic spine membrane | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0038171 | cannabinoid signaling pathway | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0071926 | endocannabinoid signaling pathway | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0098839 | postsynaptic density membrane | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0098917 | retrograde trans-synaptic signaling | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0098920 | retrograde trans-synaptic signaling by lipid | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0098921 | retrograde trans-synaptic signaling by endocannabinoid | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0099541 | trans-synaptic signaling by lipid | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0099542 | trans-synaptic signaling by endocannabinoid | 1.05% (1/95) | 7.68 | 0.004855 | 0.032902 |
GO:0043229 | intracellular organelle | 53.68% (51/95) | 0.43 | 0.004575 | 0.034015 |
GO:0043226 | organelle | 53.68% (51/95) | 0.42 | 0.005228 | 0.035295 |
GO:0050994 | regulation of lipid catabolic process | 2.11% (2/95) | 4.19 | 0.005406 | 0.035945 |
GO:1901703 | protein localization involved in auxin polar transport | 2.11% (2/95) | 4.19 | 0.005406 | 0.035945 |
GO:0006094 | gluconeogenesis | 2.11% (2/95) | 4.19 | 0.005406 | 0.035945 |
GO:0019216 | regulation of lipid metabolic process | 6.32% (6/95) | 1.91 | 0.005382 | 0.036196 |
GO:1902456 | regulation of stomatal opening | 3.16% (3/95) | 3.04 | 0.005924 | 0.038662 |
GO:0005730 | nucleolus | 9.47% (9/95) | 1.45 | 0.005885 | 0.038688 |
GO:0080167 | response to karrikin | 6.32% (6/95) | 1.88 | 0.005908 | 0.038698 |
GO:0009240 | isopentenyl diphosphate biosynthetic process | 2.11% (2/95) | 4.13 | 0.005884 | 0.038832 |
GO:0046490 | isopentenyl diphosphate metabolic process | 2.11% (2/95) | 4.13 | 0.005884 | 0.038832 |
GO:0031301 | integral component of organelle membrane | 4.21% (4/95) | 2.47 | 0.006052 | 0.039347 |
GO:0002028 | regulation of sodium ion transport | 2.11% (2/95) | 4.1 | 0.006131 | 0.039713 |
GO:0090627 | plant epidermal cell differentiation | 4.21% (4/95) | 2.46 | 0.006194 | 0.03998 |
GO:0060862 | negative regulation of floral organ abscission | 2.11% (2/95) | 4.07 | 0.006381 | 0.041036 |
GO:1903975 | regulation of glial cell migration | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0015942 | formate metabolic process | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0033609 | oxalate metabolic process | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0042426 | choline catabolic process | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:1990477 | MTREC complex | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0016710 | trans-cinnamate 4-monooxygenase activity | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0004421 | hydroxymethylglutaryl-CoA synthase activity | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0034014 | response to triglyceride | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0034696 | response to prostaglandin F | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0046690 | response to tellurium ion | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0055094 | response to lipoprotein particle | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0070543 | response to linoleic acid | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0015229 | L-ascorbic acid transmembrane transporter activity | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0015882 | L-ascorbic acid transmembrane transport | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0004013 | adenosylhomocysteinase activity | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0016802 | trialkylsulfonium hydrolase activity | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0006910 | phagocytosis, recognition | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0017185 | peptidyl-lysine hydroxylation | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0033746 | histone H3-methyl-arginine-2 demethylase activity | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0043654 | recognition of apoptotic cell | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0070077 | histone arginine demethylation | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0070078 | histone H3-R2 demethylation | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0070079 | histone H4-R3 demethylation | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0070815 | peptidyl-lysine 5-dioxygenase activity | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0042136 | neurotransmitter biosynthetic process | 1.05% (1/95) | 7.1 | 0.007274 | 0.041747 |
GO:0016740 | transferase activity | 25.26% (24/95) | 0.74 | 0.006516 | 0.041749 |
GO:1901615 | organic hydroxy compound metabolic process | 8.42% (8/95) | 1.5 | 0.007388 | 0.042264 |
GO:0023052 | signaling | 3.16% (3/95) | 2.91 | 0.00757 | 0.043165 |
GO:0006950 | response to stress | 40.0% (38/95) | 0.51 | 0.007645 | 0.043453 |
GO:0006942 | regulation of striated muscle contraction | 2.11% (2/95) | 4.01 | 0.006897 | 0.043556 |
GO:0055117 | regulation of cardiac muscle contraction | 2.11% (2/95) | 4.01 | 0.006897 | 0.043556 |
GO:1901681 | sulfur compound binding | 3.16% (3/95) | 2.97 | 0.006835 | 0.043636 |
GO:1901701 | cellular response to oxygen-containing compound | 9.47% (9/95) | 1.41 | 0.006876 | 0.04374 |
GO:0007166 | cell surface receptor signaling pathway | 5.26% (5/95) | 2.07 | 0.007042 | 0.044312 |
GO:0046890 | regulation of lipid biosynthetic process | 5.26% (5/95) | 2.03 | 0.007898 | 0.044604 |
GO:0080134 | regulation of response to stress | 15.79% (15/95) | 0.99 | 0.007888 | 0.044689 |
GO:0006739 | NADP metabolic process | 2.11% (2/95) | 3.9 | 0.007982 | 0.044793 |
GO:0019319 | hexose biosynthetic process | 2.11% (2/95) | 3.9 | 0.007982 | 0.044793 |
GO:0010243 | response to organonitrogen compound | 10.53% (10/95) | 1.28 | 0.008048 | 0.04502 |
GO:0034284 | response to monosaccharide | 4.21% (4/95) | 2.34 | 0.008172 | 0.045566 |
GO:0008406 | gonad development | 2.11% (2/95) | 3.88 | 0.008265 | 0.04594 |
GO:0050832 | defense response to fungus | 9.47% (9/95) | 1.36 | 0.008382 | 0.046442 |
GO:0005911 | cell-cell junction | 15.79% (15/95) | 0.98 | 0.008417 | 0.046493 |
GO:0042221 | response to chemical | 35.79% (34/95) | 0.55 | 0.008505 | 0.046832 |
GO:0070161 | anchoring junction | 15.79% (15/95) | 0.97 | 0.009 | 0.049401 |